This is a working overview of Tesamorelin, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-07-30. Anything still debated is marked as such rather than presented as settled.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, built from 44 amino acids. Its sequence follows the natural human GHRH(1-44) backbone, with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification blocks recognition by dipeptidyl peptidase IV, the enzyme that rapidly truncates the native hormone in circulation. The result is a molecule with a substantially longer plasma residence time than unmodified GHRH, which makes it practical for clinical and laboratory study.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | Matches human GHRH(1-44) length |
| N-terminal modification | trans-3-hexenoyl group | Confers resistance to dipeptidyl peptidase IV |
| Appearance | White to off-white powder | Typically supplied lyophilized in a sealed vial |
| Solubility class | Freely soluble in water | Hydrophilic peptide; polar solvent compatible |
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Tesamorelin binds to growth hormone-releasing hormone receptors on the surface of pituitary somatotroph cells. This binding activates adenylate cyclase, raising intracellular cyclic AMP levels and triggering the release of growth hormone into circulation. The elevated growth hormone then stimulates hepatic production of insulin-like growth factor 1. Because the effect is mediated through the endogenous axis, secretion remains subject to feedback regulation. This distinguishes it from direct growth hormone administration, which bypasses pituitary control entirely.
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Female emus court the males; the female's plumage darkens slightly and the small patches of bare, featherless skin just below the eyes and near the beak turn turquoise-blue. The colour of the male's plumage remains unchanged, although the bare patches of skin also turn light blue. When courting, females stride around, pulling their neck back while puffing out their feathers and emitting low, monosyllabic calls that have been compared to drum beats. This calling can occur when males are out of sight or more than 50 metres (160 ft) away. Once the male's attention has been gained, the female circles her prospective mate at a distance of 10 to 40 metres (30 to 130 ft). As she does this, she looks at him by turning her neck, while at the same time keeping her rump facing towards him. If the male shows interest in the parading female, he will move closer; the female continues the courtship by shuffling further away but continuing to circle him. If a male is interested, he will stretch his neck and erect his feathers, then bend over and peck at the ground. He will circle around and sidle up to the female, swaying his body and neck from side to side, and rubbing his breast against his partner's rump. Often the female will reject his advances with aggression, but if amenable, she signals acceptance by squatting down and raising her rump.
In polyarteritis nodosa, small aneurysms are strung like the beads of a rosary, therefore making this "rosary sign" an important diagnostic feature of the vasculitis. The 1990 ACR criteria were designed for classification purposes only, but their good discriminatory performance, indicated by the initial ACR analysis, suggested their potential usefulness for diagnostic purposes as well. Subsequent studies did not confirm their diagnostic utility, demonstrating a significant dependence of their discriminative abilities on the prevalence of the various vasculitides in the analyzed populations. Recently, an original study, combining the analysis of more than 100 items used to describe patients' characteristics in a large sample of vasculitides with a computer simulation technique designed to test the potential diagnostic utility of the various criteria, proposed a set of eight positively or negatively discriminating items to be used as a screening tool for diagnosis in patients suspected of systemic vasculitis.
=== Co–Coo === Philip Cohen FRS (b. 1945). At the University of Dundee known primarily for work on protein phosphorylation and ubiquitinylation. Stanley Cohen (1922–2020). American biochemist at Vanderbilt University. Nobel Prize in Physiology or Medicine (1986). Edwin Joseph Cohn (1892–1953). American protein chemist at Harvard, known for studies on blood and the physical chemistry of protein. Author, with John Edsall of Proteins, Amino Acids and Peptides, a very influential book. Member Natl. Acad. Sci. USA. Mildred Cohn (1913–2009). American biochemist, at the University of Pennsylvania, pioneer in the use of nuclear magnetic resonance to study enzyme reactions. Waldo Cohn (1910–1999). American biochemist at Oak Ridge National Laboratory, known for developing techniques for separating isotopes. Linda Columbus (active from 2002). American chemist at the University of Virginia known for work on membrane proteins. Sidney Colowick (1916–1985). American biochemist at Vanderbilt University and founding editor of Methods in Enzymology. Member Natl. Acad. Sci. USA. Minor J. Coon (1921–2018). American biochemist at the University of Michigan, Ann Arbor, discoverer of 3-hydroxy-3-methylglutaryl-CoA.
Sources: en.wikipedia.org
The only stable isotopes of thallium (81Tl) are 203Tl and 205Tl, which make up all natural thallium. The five short-lived isotopes 206Tl through 210Tl also occur in nature, but only as part of the natural decay chains of heavier elements. Synthetic radioisotopes are known from 176Tl to 217Tl; the most stable is 204Tl with a half-life of 3.78 years, followed by 202Tl (half-life 12.31 days) and 201Tl (half-life 3.0421 days). The naturally-occurring radioisotopes live minutes only, with the longest being 207Tl, with a half-life of 4.77 minutes. All isotopes of thallium are either radioactive or observationally stable, meaning that they are predicted to be radioactive but no actual decay has been observed. The isotope 204Tl is made by the neutron activation of stable thallium in a nuclear reactor. while 202Tl can be made in a cyclotron as can 201Tl (see section below). In the fully ionized state, the isotope 205Tl81+ becomes unstable, undergoing bound-state β− decay to 205Pb81+ with a half-life of 291+33−27 days, but 203Tl remains stable. 205Tl is the decay product of bismuth-209, an isotope that was once thought to be stable but is now known to undergo alpha decay with an extremely long half-life of 2.01×1019 y. Thus 205Tl is now placed at the end of the neptunium decay chain.
it reflected complex political and social motivations it was not a fascist uprising, although the Italian Social Movement led it (as viewed by leftists, that it was an interclass, inter-party and intergenerational movement, that it was an anti-state uprising (in view of the “autonomous republics”) it was spontaneous and without direction, despite Mayor Battaglia's call to strike. Some studies reported the influence of the 'ndrangheta, colluding with the right (e.g., the Baracca anarchists). Another theory is that the state and secret services were involved and used it to increase tension in the country. In the 1980s, Calabria remained undeveloped. It was dominated by power groups linked to organized crime and deviant freemasonry. Social and economic initiatives, barely advanced, assuming the availability of human and other resources that did not exist. Many (expensive) works mostly benefited a few entrepreneurs rather than the masses. The 'Ndrangheta began to make headlines thanks to its ransom kidnappings (such as the one of John Paul Getty III, grandson of J. Paul Getty, onetime world's richest man who was taken in 1973 and released upon payment of a one billion seven hundred million lire ransom). In the 1980s, they turned to narcotics trafficking, forging contacts with South American drug cartels and feuding with Mafia clans for control of territory. As in Sicily, the 'ndrangheta infiltrated the politics, placing its people in municipal administrations.
=== Thyroid cancer === At exposures eight times greater than those used in humans, liraglutide caused a statistically significant increase in thyroid tumors in rats. The clinical relevance of these findings is unknown. In clinical trials, the rate of thyroid tumors in participants treated with liraglutide was 1.3 per 1000 participant years (4 people) compared to 1.0 per 1000 participants (1 person) in comparison groups. The sole participant in the comparator group and four of the five participants in the liraglutide group had serum markers (elevated calcitonin) suggestive of pre-existing disease at baseline. The US Food and Drug Administration (FDA) said serum calcitonin, a biomarker of medullary thyroid cancer, was slightly increased in liraglutide patients, but still within normal ranges, and it required ongoing monitoring for 15 years in a cancer registry.
Sources: en.wikipedia.org
== References == Chagot B, Escoubas P, Villegas E, Bernard C, Ferrat G, Corzo G, Lazdunski M, Darbon H (2004). "Solution structure of Phrixotoxin 1, a specific peptide inhibitor of Kv4 potassium channels from the venom of the theraphosid spider Phrixotrichus auratus". Protein Sci. 13 (5): 1197–208. doi:10.1110/ps.03584304. PMC 2286752. PMID 15096626. Diochot S, Drici MD, Moinier D, Fink M, Lazdunski M (1999). "Effects of phrixotoxins on the Kv4 family of potassium channels and implications for the role of Ito1 in cardiac electrogenesis". Br J Pharmacol. 126 (1): 251–63. doi:10.1038/sj.bjp.0702283. PMC 1565788. PMID 10051143. Bosmans F, Rash L, Zhu S, Diochot S, Lazdunski M, Escoubas P, Tytgat J (2006). "Four novel tarantula toxins as selective modulators of voltage-gated sodium channel subtypes". Mol Pharmacol. 69 (2): 419–29. doi:10.1124/mol.105.015941. PMID 16267209. S2CID 10093118.
The NHS Grampian health board announcing it is to divert ambulance patients to hospitals outside its area because of "critical" pressure on its largest hospital. 29 November – Finlay MacDonald, who carried out a series of shootings on the Isle of Skye and the Scottish mainland, which included the fatal shooting of his brother-in-law, is sentenced to life imprisonment with a minimum term of 28 years. GP leaders in Scotland vote in favour of a motion to ballot workers on industrial action over pay, following what they describe as "years of disinvestment in general practice". 30 November – The Proclaimers perform at a memorial service for former first minister Alex Salmond, held at Edinburgh's St Giles' Cathedral.
== Morphology == An animal's hump is formed by neural spines on the thoracic vertebrae. Despite only being known from the fossil record, the woolly mammoth and species of the genus Titanotylopus are assumed to have had humps due to the presence of such spines in their skeletons. In the gaur, the hump is formed solely because of the skeletal structure, as its third to eleventh vertebrae have such spines. In both dromedaries and bactrian camels, humps are attached to the adipose tissue in the dorsal region, and fixed in place by the trapezius and rhomboid muscles.
On 17 October 1971, Gajowniczek was a special guest of Pope Paul VI in the Vatican when Maximilian Kolbe was beatified for his martyrdom. In 1972, Time magazine reported that over 150,000 people made a pilgrimage to Auschwitz to honor the anniversary of Kolbe's beatification. One of the first to speak was Gajowniczek, who declared "I want to express my thanks for the gift of life." His wife, Helena, died in 1977. Gajowniczek was in the Vatican once again, this time as a guest of Pope John Paul II, when Kolbe was canonized on 10 October 1982. In 1994, Gajowniczek visited St. Maximilian Kolbe Catholic Church of West Chester, Pennsylvania and also in Houston, Texas, where he told his translator Chaplain Thaddeus Horbowy that "so long as he ... has breath in his lungs, he would consider it his duty to tell people about the heroic act of love by Maximilian Kolbe." Gajowniczek died in the city of Brzeg on 13 March 1995 at the age of 93. He was buried at Niepokalanów, a religious community founded by Maximilian Kolbe, 53 years after Kolbe saved his life. He was survived by his second wife, Janina.
Sources: en.wikipedia.org
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.
No. It is a receptor agonist that stimulates the pituitary to release endogenous growth hormone. It does not contain or deliver growth hormone. Its downstream effects therefore depend on a functioning pituitary and an intact signaling pathway.
Pituitary responsiveness, receptor availability, and the natural pulsatility of the growth hormone axis all contribute. Because the compound amplifies an existing release pattern rather than overriding it, timing and physiological state matter. Individual variability in response is well documented but not fully explained.
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.